Background/Aim: Osteosarcoma is the most frequent malignant bone tumor. Failure of first-line therapy results in poor prognosis osteosarcoma. In present report, we examined efficacy combination oral recombinant methioninase (o-rMETase) and docetaxel (DOC) on an osteosarcoma patient-derived orthotopic xenograft (PDOX) mouse model. Materials Methods: Osteosarcoma-PDOX models were established by t...

objective(s): the present study was designed to investigate the antibacterial function and pharmacological effect of elephant garlic (allium ampeloprasum var. ampeloprasum) on u2os human osteosarcoma cells.   materials and methods: seven kinds of bacteria were reconstituted, inoculated and tested in this research to evaluate elephant garlic antibacterial activity. by the means of facs analysis,...

Osteosarcoma is a common primary malignant bone tumor in young adults presenting with back and chest pain complaints. Here, we presented rare case of osteosarcoma.

  Objective(s): The present study was designed to investigate the antibacterial function and pharmacological effect of elephant garlic (Allium ampeloprasum var. ampeloprasum) on U2OS human osteosarcoma cells.   Materials and Methods: Seven kinds of bacteria were reconstituted, inoculated and tested in this research to evaluate elephant garlic antibacterial activity. By the means ...

Osteosarcoma, the most common bone cancer, leads to a poor survival rate of patients. Drug targeting employing hydroxyapatite (HAp)-based nanocarriers represents fascinating choice for non-invasive treatment osteosarcoma.

Osteosarcoma of the foot is exceedingly uncommon, and as a result, very little known about patient tumor characteristics. In addition, prognosis may be grim due to delayed presentation misdiagnosis. A diagnosis osteosarcoma, regardless location, not only reduce long-term survival but also modify treatment plan, resulting in less favorable functional cosmetic outcomes. Here we report diagnostic ...